Nuvalent, Inc. (NUVL)
NASDAQ·Healthcare·Biotechnology
$123.96
—
Mkt Cap $9.13B
Analyst Ratings
Buy
4
Hold
10
Sell
0
Price Target (33 analysts)
$127.32
Range $122.85 – $165.00
Implied Upside
+2.7%
Consensus $127.32 vs current $123.96
NASDAQ·Healthcare·Biotechnology
$123.96
—
Mkt Cap $9.13B
Buy
4
Hold
10
Sell
0
Price Target (33 analysts)
$127.32
Range $122.85 – $165.00
+2.7%
Consensus $127.32 vs current $123.96